Tags

Type your tag names separated by a space and hit enter

Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
Microb Drug Resist. 2010 Mar; 16(1):55-60.MD

Abstract

The prevalence and molecular types of extended-spectrum beta-lactamases (ESBLs) were determined during a 1-year period in unselected clinical nonduplicate isolates of Escherichia coli (n = 1,738), Klebsiella pneumoniae (n = 436), and Klebsiella oxytoca (n = 208), cultured at the University Medical Centre Nijmegen, The Netherlands. Isolates identified as ESBL producer by the Phoenix automated system were collected prospectively and subjected to molecular analysis for the most common ESBLs TEM, SHV, and CTX-M, as well as OXA and GES. Both the Etest ESBL and double-disk synergy test were performed as confirmatory tests. The estimated prevalence of ESBLs was 2.1% in E. coli, 5.2% in K. pneumoniae, and 2.4% in K. oxytoca. TEM-12 and -26, SHV-5 and -12, and CTX-M groups 1 and 9 were the most frequent ESBLs found. Isolates identified as ESBLs by the Phoenix were confirmed by polymerase chain reaction (PCR) in only 42%. In ESBL PCR-positive E. coli and K. pneumoniae, both confirmatory tests were positive in 95% of the isolates. In 28% of the Etest and 13% of the double-disk synergy test-positive isolates, PCR could not detect any ESBL gene. In these cases, other resistance mechanisms may play a role. Confirmatory tests were unreliable for K. oxytoca. A previously described mutation in the K1 enzyme was detected in one ceftazidime-resistant K. oxytoca. The prevalence of ESBLs in The Netherlands is increasing. The predominant molecular types of ESBLs detected were comparable to other studies. Phoenix ESBL results need to be confirmed as advocated by ESBL detection guidelines.

Authors+Show Affiliations

Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands. p.sturm@mmb.umcn.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

20001741

Citation

Sturm, Patrick D J., et al. "Prevalence, Molecular Characterization, and Phenotypic Confirmation of Extended-spectrum Beta-lactamases in Escherichia Coli, Klebsiella Pneumoniae, and Klebsiella Oxytoca at the Radboud University Nijmegen Medical Centre in the Netherlands." Microbial Drug Resistance (Larchmont, N.Y.), vol. 16, no. 1, 2010, pp. 55-60.
Sturm PD, Bochum ET, van Mook-Vermulst SV, et al. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Microb Drug Resist. 2010;16(1):55-60.
Sturm, P. D., Bochum, E. T., van Mook-Vermulst, S. V., Handgraaf, C., Klaassen, T., & Melchers, W. J. (2010). Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Microbial Drug Resistance (Larchmont, N.Y.), 16(1), 55-60. https://doi.org/10.1089/mdr.2009.0107
Sturm PD, et al. Prevalence, Molecular Characterization, and Phenotypic Confirmation of Extended-spectrum Beta-lactamases in Escherichia Coli, Klebsiella Pneumoniae, and Klebsiella Oxytoca at the Radboud University Nijmegen Medical Centre in the Netherlands. Microb Drug Resist. 2010;16(1):55-60. PubMed PMID: 20001741.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. AU - Sturm,Patrick D J, AU - Bochum,Els T M, AU - van Mook-Vermulst,Sacha V M, AU - Handgraaf,Cindy, AU - Klaassen,Twan, AU - Melchers,Willem J G, PY - 2009/12/17/entrez PY - 2009/12/17/pubmed PY - 2010/6/15/medline SP - 55 EP - 60 JF - Microbial drug resistance (Larchmont, N.Y.) JO - Microb Drug Resist VL - 16 IS - 1 N2 - The prevalence and molecular types of extended-spectrum beta-lactamases (ESBLs) were determined during a 1-year period in unselected clinical nonduplicate isolates of Escherichia coli (n = 1,738), Klebsiella pneumoniae (n = 436), and Klebsiella oxytoca (n = 208), cultured at the University Medical Centre Nijmegen, The Netherlands. Isolates identified as ESBL producer by the Phoenix automated system were collected prospectively and subjected to molecular analysis for the most common ESBLs TEM, SHV, and CTX-M, as well as OXA and GES. Both the Etest ESBL and double-disk synergy test were performed as confirmatory tests. The estimated prevalence of ESBLs was 2.1% in E. coli, 5.2% in K. pneumoniae, and 2.4% in K. oxytoca. TEM-12 and -26, SHV-5 and -12, and CTX-M groups 1 and 9 were the most frequent ESBLs found. Isolates identified as ESBLs by the Phoenix were confirmed by polymerase chain reaction (PCR) in only 42%. In ESBL PCR-positive E. coli and K. pneumoniae, both confirmatory tests were positive in 95% of the isolates. In 28% of the Etest and 13% of the double-disk synergy test-positive isolates, PCR could not detect any ESBL gene. In these cases, other resistance mechanisms may play a role. Confirmatory tests were unreliable for K. oxytoca. A previously described mutation in the K1 enzyme was detected in one ceftazidime-resistant K. oxytoca. The prevalence of ESBLs in The Netherlands is increasing. The predominant molecular types of ESBLs detected were comparable to other studies. Phoenix ESBL results need to be confirmed as advocated by ESBL detection guidelines. SN - 1931-8448 UR - https://www.unboundmedicine.com/medline/citation/20001741/Prevalence_molecular_characterization_and_phenotypic_confirmation_of_extended_spectrum_beta_lactamases_in_Escherichia_coli_Klebsiella_pneumoniae_and_Klebsiella_oxytoca_at_the_Radboud_University_Nijmegen_Medical_Centre_in_The_Netherlands_ L2 - https://www.liebertpub.com/doi/10.1089/mdr.2009.0107?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -